April 27 — Chicago, IL — Welcome to the inaugural issue of Urology Times E-news, featuring dailynews reports from the AUA annual meeting on your desktop. And, if you'reattending this year's meeting, welcome to Chicago!
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.